1. Medtech Insight
  2. >>Policy & Regulation

Biotronik Pays Almost $13M To Resolve Physician Kickback Allegations

 
• By Elizabeth Orr

The company reportedly abused an employee training program by funneling payments to favored physicians to encourage them to use Biotronik products.

wooden gavel with usa dollar on desk. close up. toned image
• Source: Shutterstock

Biotronik has agreed to pay $12.95m to settle allegations the company paid kickbacks to physicians to encourage the use of its implantable cardiac devices, the US Department of Justice announced on 22 July.

The civil settlement resolves charges that the company had violated the False Claims Act by improperly influencing physicians to use Biotronik defibrillators and pacemakers, thereby causing fraudulent claims to be submitted to Medicare and other government health programs

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Compliance

More from Policy & Regulation

Does Makary’s Reorg Choice Mark FDA Turning Point?

 
• By Michael McCaughan

US FDA Commissioner Martin Makary’s disavowal of a proposed reorganization plan may be an important turning point in the Trump Administration. The move does not improve the situation, but may mean the administration stops actively making things worse.

MedTech Europe’s Bisazza Urges Action As US Tariffs Jeopardize Critical Global Supply Chains

 
• By Amanda Maxwell

The intricate assembly of medical devices, often involving over 1,000 globally sourced components, faces severe disruption due to new US tariffs. These barriers could halt production and devastate small and medium-sized enterprises (SMEs), MedTech Europe’s CEO, Oliver Bisazza, warns in an interview with Medtech Insight.

New Treatment For Chronic Facial Pain Could Launch By Fall 2025

 
• By Elizabeth Orr

NeuroOne is preparing to submit its OneRF Trigeminal Nerve Ablation System to the US FDA for treating trigeminal neuralgia, a chronic facial pain condition. CEO Dave Rosa told Medtech Insight that he expects a possible product launch by fall 2025.